Impact of per- and polyfluoroalkyl substances exposure on renal dysfunction: Integrating epidemiological evidence
Weitao Su1, Ziwen An2, Yayuan Mei3
1Central Laboratory, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, 362000, China.
Abstract:
Renal dysfunction poses a growing global health burden, yet the role of environmental contaminants like per- and polyfluoroalkyl substances (PFAS), particularly their underlying mechanisms, remains understudied. This cross-sectional study included 2801 adults from North China (Shijiazhuang and Baoding City). Plasma concentrations of 21 legacy and alternative PFAS were quantified via ultra-high-performance liquid chromatography-tandem mass spectrometry. Renal function markers (serum creatinine (SCr), serum uric acid (SUA), SUA to SCr ratio (SUA/SCr), blood urea nitrogen (BUN), BUN to SCr ratio (BUN/SCr), estimated glomerular filtration rate (eGFR)) and inflammatory markers were assessed. Multivariable linear regression and quantile g-computation evaluated individual and mixture effects. Receiver operating characteristic (ROC) analysis assessed renal markers' predictive ability for PFAS. Mediation analysis investigated the role of inflammatory markers, while bioinformatics explored molecular mechanisms. Nine PFAS demonstrated significant associations with elevated SCr, SUA, SUA/SCr, BUN, BUN/SCr, or reduced eGFR. Notably, perfluorooctanesulfonic acid (PFOS) exhibited concurrent associations with SCr, SUA, BUN, and eGFR. PFAS mixtures were linked to increased SCr, SUA, SUA/SCr, BUN, and decreased eGFR. PFOS and perfluorooctanoic acid (PFOA) contributed most to eGFR decline and SUA elevation, respectively. ROC analysis demonstrated superior predictive performance of renal biomarkers for PFOS. Inflammatory markers significantly mediated PFAS (particularly PFOS)-renal dysfunction associations. Bioinformatics implicated lipid metabolism dysregulation and peroxisome proliferator-activated receptor (PPAR) signaling disruption as key mechanisms. In conclusion, PFAS exposure, especially PFOS, was associated with renal dysfunction, mediated primarily by inflammation and lipid metabolism. These findings provide critical mechanistic insights for developing prevention and management strategies against PFAS-associated renal dysfunction.
More Related Videos
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations


